Compare AZTA & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AZTA | ENOV |
|---|---|---|
| Founded | 1978 | 1995 |
| Country | United States | United States |
| Employees | N/A | 7802 |
| Industry | Industrial Machinery/Components | Fluid Controls |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 1996 | 2008 |
| Metric | AZTA | ENOV |
|---|---|---|
| Price | $39.25 | $27.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 13 |
| Target Price | ★ $37.80 | $36.08 |
| AVG Volume (30 Days) | 862.9K | ★ 1.5M |
| Earning Date | 11-10-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $593,821,000.00 | N/A |
| Revenue This Year | $3.53 | $4.05 |
| Revenue Next Year | $3.98 | $4.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.93 | $16.70 |
| 52 Week High | $46.41 | $32.41 |
| Indicator | AZTA | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 55.20 | 69.99 |
| Support Level | $30.75 | $20.87 |
| Resistance Level | $41.71 | $27.50 |
| Average True Range (ATR) | 2.12 | 1.39 |
| MACD | -0.07 | 0.76 |
| Stochastic Oscillator | 63.38 | 74.45 |
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.